Form 8-K - Current report:
SEC Accession No. 0001171843-23-003943
Filing Date
2023-06-15
Accepted
2023-06-15 11:15:33
Documents
12
Period of Report
2023-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_061523.htm   iXBRL 8-K 28709
  Complete submission text file 0001171843-23-003943.txt   203561

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cmpx-20230615.xsd EX-101.SCH 2974
3 XBRL LABEL FILE cmpx-20230615_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cmpx-20230615_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_061523_htm.xml XML 3714
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 231016387
SIC: 2836 Biological Products, (No Diagnostic Substances)